Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand in the U.S....

FOR years stay-at-home mum Natalie Strange tried everything to lose weight – all the trendy diets, calorie counting, you name it.So when...

The Colorado legislature debated more than 600 bills at the state Capitol this year during the lawmaking term that ended Wednesday.The C...

Stock futures advanced Wednesday as investors monitored the latest updates on U.S. trade negotiations and looked toward the Federal Reserve...

WeightWatchers said Tuesday it is filing for Chapter 11 bankruptcy protection to eliminate $1.15 billion in debt and focus on its transition...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

NEW YORK (AP) — WeightWatchers said Tuesday it is filing for Chapter 11 bankruptcy protection to eliminate $1.15 billion in debt and focus o...

NO doubt you’ve heard the warnings. Drugs to treat conditions of all shapes and sizes come with side effects – often unpleasant, dangerous,...

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS.Research by Harley Street Sk...

Around 1.5 million people a month in Britain are paying privately for weight-loss jabs as demand for the drugs continues to soar, a leading...

Weight-loss drugs like Ozempic and Wegovy are sending dozens of Americans to the hospital every day with potentially life-threatening side e...

Wegovy® will be the preferred GLP-1 medicine for obesity on the largest commercial template formularies for CVS Caremark, the largest Pharma...

The anticipated integration of Google’s Gemini AI into iPhones represents a significant moment in the ongoing evolution of artificial...

Recent warnings from top virologists highlight the escalating threat posed by the H5N1 avian influenza virus, which has rapidly spread acros...

The recent advancements in the treatment of liver diseases, particularly metabolic dysfunction-associated steatohepatitis (MASH) and non-alc...